Below you can find the most recent stocks that we have issued original research on, or updates to original research.
Fitlife Brands Inc (OTC:FTLF) ($17.29; $76.8M market cap), a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally, filed an 8K showing it has acquired all the assets of Muscle Pharm Corp (OTC:MSLPQ) in Bankruptcy Court.
FTLF was one of the recent additions to our Buy on Pullback model portfolio we disclosed on September 24, 202...
New Reasons For Tracking (RFT) on CSPI
Csp Inc. (NASDAQ:CSPI) ($17.45; $82.4M market cap) develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose built network adapters, and cluster computer systems for commercial and defense customers worldwide.
CSPI has been a stock we’ve been watching for some time to see if management could addres...
Trio-Tech Intl (NYSE AMEX:TRT) ($8.14; $33.3M market cap) together with its subsidiaries, offers manufacturing, testing, and distribution services to the semiconductor industry. Shares of TRT have been hitting new 52 week highs, reaching $8.52 in yesterday’s trading session. It is likely a delayed reaction to Q3 2023 EV order news. While the Q3 2023 results were less than stellar:
Sales o...
Lifevantage Corporation (NASDAQ:LFVN) ($6.52; $82.7 M market cap) -
Lifevantage engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management, skin and hair care, bath and body, and targeted relief products.
We are watching LFVN due to an ongoing proxy battle with activist...
Coda Octopus Group, Inc. (NASDAQ:CODA) ($7.48; 83.1M market cap) a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for real-time subsea intelligence and diving technology, announced Q3 2023 results:
Sales of $4.9 million vs $6.3 million in the prior year and below analyst estimates of $6.2
EPS of $0.09 vs $0.16 in the prior year and below analyst estimates of $0.12...